EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Corneal Neovascularisation and Anti-VEGF Therapy

Elsie Chan, Jennifer Fan Gaskin, Elsa C. Chan

Targets · 10.03.2025 · 3 (1) · 9

DOI: 10.3390/targets3010009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Targets, online erschienen am 10.03.2025. Verfasst von Elsie Chan und 2 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Melbourne Annemarie Mankiewicz-Zelkin Fellowship.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cornea vascularisation is a significant cause of ocular morbidity. Disease or injury often triggers the development of new blood vessels in the cornea, compromising its clarity and impairing vision. Common causes of corneal neovascularisation include infections, chemical burns, and local and systemic inflammatory disorders. Topical corticosteroid eye drops remain the standard therapy; however, extended use of corticosteroids has been known to cause side-effects including cataracts and raised intraocular pressure. As such, an alternative therapy has been actively sought. Vascular endothelial growth factor (VEGF) is a major angiogenic factor implicated in neovascularisation. The success of anti-VEGF agents in managing leaking blood vessels in neovascular age-related macular degeneration provides an opportunity to explore its use in the treatment of corneal neovascularisation. The therapeutic potential of anti-VEGF agents has been evaluated in experimental models of corneal neovascularisation and clinical trials with variable results. Here, we review the study results and discuss the development of new strategies that may improve treatment outcomes for corneal neovascularisation.

Förderung

  • University of Melbourne Annemarie Mankiewicz-Zelkin Fellowship

Zitieren

APA

Chan, E., Gaskin, J. F., & Chan, E. C. (2025). Corneal Neovascularisation and Anti-VEGF Therapy. Targets, 3(1), 9. https://doi.org/10.3390/targets3010009

Vancouver

Chan E, Gaskin JF, Chan EC. Corneal Neovascularisation and Anti-VEGF Therapy. Targets. 2025;3(1):9. doi:10.3390/targets3010009

BibTeX
@article{Chan2025,
  author = {Chan, Elsie and Gaskin, Jennifer Fan and Chan, Elsa C.},
  title = {Corneal Neovascularisation and Anti-VEGF Therapy},
  journal = {Targets},
  year = {2025},
  volume = {3},
  number = {1},
  pages = {9},
  doi = {10.3390/targets3010009}
}
Kostenlos starten →